157 related articles for article (PubMed ID: 17867604)
1. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
[TBL] [Abstract][Full Text] [Related]
2. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.
Wild PJ; Giedl J; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
J Pathol; 2007 Jan; 211(1):18-25. PubMed ID: 17072825
[TBL] [Abstract][Full Text] [Related]
3. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
4. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
5. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
6. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
[TBL] [Abstract][Full Text] [Related]
7. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
8. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.
Eiber M; van Oers JM; Zwarthoff EC; van der Kwast TH; Ulrich O; Helpap B; Stoerkel S; Blaszyk H; Cheville J; Sauter G; Wild PJ; Stoehr R; Hofstaedter F; Hartmann A
Am J Surg Pathol; 2007 Jun; 31(6):938-46. PubMed ID: 17527084
[TBL] [Abstract][Full Text] [Related]
10. [Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis].
Habuchi T; Kato T; Takahashi T; Ogawa O
Hinyokika Kiyo; 2000 Oct; 46(10):749-55. PubMed ID: 11215205
[TBL] [Abstract][Full Text] [Related]
11. [Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
Burger M; Catto J; van Oers J; Zwarthoff E; Hamdy FC; Meuth M; Azzouri AR; Cussenot O; Wild PJ; Stoehr R; Hartmann A
Verh Dtsch Ges Pathol; 2006; 90():244-52. PubMed ID: 17867603
[TBL] [Abstract][Full Text] [Related]
12. High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers.
Kawanishi H; Takahashi T; Ito M; Watanabe J; Higashi S; Kamoto T; Habuchi T; Kadowaki T; Tsujimoto G; Nishiyama H; Ogawa O
Cancer Sci; 2006 Aug; 97(8):746-52. PubMed ID: 16863508
[TBL] [Abstract][Full Text] [Related]
13. Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer.
Burger M; Burger SJ; Denzinger S; Wild PJ; Wieland WF; Blaszyk H; Obermann EC; Stoehr R; Hartmann A
Eur Urol; 2006 Oct; 50(4):770-5; discussion 776. PubMed ID: 16762487
[TBL] [Abstract][Full Text] [Related]
14. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors.
Takahashi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Kato T; Ogawa O; Habuchi T
J Urol; 2001 Feb; 165(2):672-7. PubMed ID: 11176456
[TBL] [Abstract][Full Text] [Related]
15. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
17. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
18. TGF-betaRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder.
Saetta AA; Korkolopoulou P; Karlou M; Levidou G; Goudopoulou A; Thymara I; Stamatelli A; Tzivras M; Michalopoulos NV; Thomas-Tsagli E; Patsouris E
Pathology; 2007 Aug; 39(4):425-32. PubMed ID: 17676485
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
Lindgren D; Liedberg F; Andersson A; Chebil G; Gudjonsson S; Borg A; Månsson W; Fioretos T; Höglund M
Oncogene; 2006 Apr; 25(18):2685-96. PubMed ID: 16532037
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
